Drug name - Xtoro

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9119859 MERLION PHARMS GMBH Methods for treating otic infections Jul, 2030

(7 years from now)

US8536167 MERLION PHARMS GMBH Methods for treating ophthalmic, otic, or nasal infections Aug, 2031

(8 years from now)

US9504691 MERLION PHARMS GMBH Finafloxacin suspension compositions Nov, 2033

(11 years from now)

Drugs and Companies using FINAFLOXACIN ingredient

Treatment: Treatment of acute otitis externa

Dosage: SUSPENSION/DROPS;OTIC

More Information on Dosage
Strength Dosage Availability
0.3% SUSPENSION/DROPS;OTIC Discontinued

availability in other generic markets.

Click on the highlighted region to filter.